Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

HHS Human Subject Protection Team Will Include Former FDAer Nightingale

This article was originally published in The Gray Sheet

Executive Summary

Former FDA Associate Commissioner for Health Affairs Stuart Nightingale, MD, will work on human subject protection issues as one of his responsibilities in a new position at HHS.

You may also be interested in...



FDA Civil Monetary Penalties For Human Subject Protection Sought By HHS

HHS plans to submit a legislative proposal to Congress by year-end that would authorize FDA to levy civil monetary penalties for infractions of human research subject protections rules, the Clinton administration announced May 23.

FDA Civil Monetary Penalties For Human Subject Protection Sought By HHS

HHS plans to submit a legislative proposal to Congress by year-end that would authorize FDA to levy civil monetary penalties for infractions of human research subject protections rules, the Clinton administration announced May 23.

Investigators Not Adhering To Good Clinical Practices - Henney

Clinical investigators of medical devices and drugs frequently are not following standards for good clinical practices, FDA Commissioner Henney, MD, maintained at a May 11 meeting of the Association of American Medical Colleges.

Latest Headlines
See All
UsernamePublicRestriction

Register

MT013403

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel